Rupoli S - Search Results

1

Alfa-interferon in the treatment of essential thrombocythemia: clinical results and evaluation of its biological effects on the hematopoietic neoplastic clone. Italian Cooperative Group on ET.

Sacchi S, Gugliotta L, Papineschi F, Liberati AM, Rupoli S, Delfini C, Ruggeri M, Cavanna L, Bucalossi A, Benedetti E, Ferrandina C, Vinci G, Morselli M, Torelli G. Sacchi S, et al. Among authors: rupoli s. Leukemia. 1998 Mar;12(3):289-94. doi: 10.1038/sj.leu.2400931. Leukemia. 1998. PMID: 9529121 Clinical Trial.

2

Interferon alpha-2b in the long-term treatment of essential thrombocythemia.

Sacchi S, Tabilio A, Leoni P, Riccardi A, Vecchi A, Messora C, Falzetti F, Rupoli S, Ucci G, Martelli MF. Sacchi S, et al. Among authors: rupoli s. Ann Hematol. 1991 Oct;63(4):206-9. doi: 10.1007/BF01703444. Ann Hematol. 1991. PMID: 1932299

3

All-trans retinoic acid (ATRA) in patients with chronic myeloid leukemia in the chronic phase.

Russo D, Regazzi M, Sacchi S, Visani G, Lazzarino M, Avvisati G, Pelicci PG, Dastoli G, Grandi C, Iacona I, Candoni A, Grattoni R, Galieni P, Rupoli S, Liberati AM, Maiolo AT. Russo D, et al. Among authors: rupoli s. Leukemia. 1998 Apr;12(4):449-54. doi: 10.1038/sj.leu.2400988. Leukemia. 1998. PMID: 9557600 Clinical Trial.

4

Diagnosis of essential thrombocythemia at platelet counts between 400 and 600x10(9)/L. Gruppo Italiano Malattie Mieloproliferative Croniche(GIMMC).

Sacchi S, Vinci G, Gugliotta L, Rupoli S, Gargantini L, Martinelli V, Baravelli S, Lazzarino M, Finazzi G. Sacchi S, et al. Among authors: rupoli s. Haematologica. 2000 May;85(5):492-5. Haematologica. 2000. PMID: 10800165

5

Sustained complete hematological remission in essential thrombocythemia after discontinuation of long-term alpha-IFN treatment.

Sacchi S, Tabilio A, Leoni P, Riccardi A, Vecchi A, Messora C, Bensi L, Falzetti F, Rupoli S, Ucci G, et al. Sacchi S, et al. Among authors: rupoli s. Ann Hematol. 1993 May;66(5):245-6. doi: 10.1007/BF01738473. Ann Hematol. 1993. PMID: 8507719

6

A prospective comparison between treatment with phlebotomy alone and with interferon-alpha in patients with polycythemia vera.

Sacchi S, Leoni P, Liberati M, Riccardi A, Tabilio A, Tartoni P, Messora C, Vecchi A, Bensi L, Rupoli S, et al. Sacchi S, et al. Among authors: rupoli s. Ann Hematol. 1994 May;68(5):247-50. doi: 10.1007/BF01737425. Ann Hematol. 1994. PMID: 8018766 Clinical Trial.

7

Clinical activity and safety of combination immunotherapy with IFN-alpha 2a and Rituximab in patients with relapsed low grade non-Hodgkin's lymphoma.

Sacchi S, Federico M, Vitolo U, Boccomini C, Vallisa D, Baldini L, Petrini M, Rupoli S, Di Raimondo F, Merli F, Liso V, Tabilio A, Saglio G, Vinci G, Brugiatelli M, Dastoli G; GISL. Sacchi S, et al. Among authors: rupoli s. Haematologica. 2001 Sep;86(9):951-8. Haematologica. 2001. PMID: 11532623 Free article. Clinical Trial.

8

Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia.

Barosi G, Ambrosetti A, Centra A, Falcone A, Finelli C, Foa P, Grossi A, Guarnone R, Rupoli S, Luciano L, Petti MC, Pogliani E, Russo D, Ruggeri M, Quaglini S. Barosi G, et al. Among authors: rupoli s. Blood. 1998 May 15;91(10):3630-6. Blood. 1998. PMID: 9572998 Free article.

9

Unbiased pro-thrombotic features at diagnosis in 977 thrombocythemic patients with Philadelphia-negative chronic myeloproliferative neoplasms.

Gugliotta L, Iurlo A, Gugliotta G, Tieghi A, Specchia G, Gaidano G, Scalzulli PR, Rumi E, Dragani A, Martinelli V, Santoro C, Randi ML, Tagariello G, Candoni A, Cattaneo D, Ricco A, Palmieri R, Liberati MA, Langella M, Rago A, Bergamaschi M, Monari P, Miglio R, Santoro U, Cacciola R, Rupoli S, Mastrullo L, Musto P, Mazzucconi MG, Vignetti M, Cortelezzi A, Vianelli N, Martino B, De Stefano V, Passamonti F, Vannucchi AM; Registro Italiano Trombocitemie RIT. Gugliotta L, et al. Among authors: rupoli s. Leuk Res. 2016 Jul;46:18-25. doi: 10.1016/j.leukres.2016.04.004. Epub 2016 Apr 7. Leuk Res. 2016. PMID: 27107744

10

Time-Dependent Kinetics of Tretinoin in Chronic Myelogenous Leukaemia during Intermittent Dose Scheduling: 1 Week On/1 Week Off.

Regazzi MB, Russo D, Iacona I, Sacchi S, Visani G, Lazzarino M, Avvisati G, Pelicci PG, Dastoli G, Grandi C, Spreafico S, Grattoni R, Galieni P, Rupoli S, Maiolo AM, Guerra E, Liberati AM. Regazzi MB, et al. Among authors: rupoli s. Clin Drug Investig. 1998;16(1):25-33. doi: 10.2165/00044011-199816010-00004. Clin Drug Investig. 1998. PMID: 18370515

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page